PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,067 stories, page 63 of 802

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Tempus AI: Moderna's New Cancer Vaccine Partner Is The Pick Of The AI Biotech Bunch

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

People in a heart muscle disease trial averaged 59 on a 100-point symptom score, showing substantial symptoms.

Stock TitanOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Chutes & Ladders—Troubled CSL enlists GSK vet Deborah Waterhouse to lead

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class H Estimates – MUN:08HH

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, Inc. Estimates – BOATS:WST

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and history

Yahoo Finance UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sartorius Stedim Biotech SA Unsponsored ADR Estimates – FWB:56S0

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Humacyte at ASN Kidney Week: Phase 3 Trial Built for Women Shows ATEV Advantage Over Fistula, Getting Patients Off Catheters Months Sooner

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VAT and Portugal’s pharmaceutical industry: from landmark litigation to new recovery opportunities

International Tax ReviewOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

WorkWell Pilots Evaluation Early Implementation Findings

This report presents the emerging findings from the evaluation of the 15 WorkWell programme pilots,...

UK Department of Health and Social CareOriginal source
🇪🇸Regulatoryaemps.gob.esTier 1 · Regulatory source

La AEMPS informa del riesgo de bloqueo incompleto de los carros LUNA X5 para elevadores de techo

AEMPS (Spain)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech, Inc. Estimates – NASDAQ:KRYS

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Protecting data quality in pharmaceutical supply chains

Manufacturing ChemistOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CSPC Pharmaceutical Group Limited Estimates – HKEX:1093

TradingViewOriginal source
🇺🇰Researchmft.nhs.ukTier 2 · Direct publisher

First patient in the UK to receive gene-editing therapy for sickle cell completes treatment

Manchester University NHS Foundation TrustOriginal source
🇯🇵Researchkyoto-u.ac.jpTier 2 · Direct publisher

Executive Vice-President Tetsuo Sawaragi attends the Japan-Africa Universities Exchange Meeting 2026

Kyoto UniversityOriginal source
🌍Researchanswers.childrenshospital.orgTier 2 · Direct publisher

Fighting for — and with —Kiara through congenital diaphragmatic hernia care

Boston Children's HospitalOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC: workforce management information

Documents relating to workforce management information summary data for the Department of Health and...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC: workforce management information September 2026

Reports on departmental staff numbers and costs.

UK Department of Health and Social CareOriginal source
🇺🇰Researchguysandstthomas.nhs.ukTier 2 · Direct publisher

Guy's and St Thomas' Advanced Therapies Programme and the Patient Perspective

St Thomas' Hospital LondonOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda proposes banning large-scale compounding of popular weight-loss drugs

www.polskieradio.plOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Star Therapeutics Raises $200 Million to Advance Drug Pipeline Following $2 Billion Vega Therapeutics Deal

citybizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines Reports RASONQUE Shows Consistent Overall Survival Benefit Across Key Subgroups in Phase 3 RASolute 302 Trial

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda concerns unapproved glp-1 drugs weight loss retatrutide

BusinessWorld OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda weight loss drug news today october 2025

BusinessWorld OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

In a trial, patients on an experimental stomach cancer drug lived a median 10.2 months, vs. 6.9 on other treatments.

Stock TitanOriginal source
🇺🇸Industrybristolmyers2016ir.q4web.comTier 3 · Secondary coverage

Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Breast Cancer in Phase 3 PANKU-Breast01 Study

Bristol-Myers Squibb NewsOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Roche pays Zymeworks $55M for trispecific challenger to Amgen’s Imdelltra

Fierce BiotechOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

New mental health pilot for young people supported by social care

Young people supported by social care in Greater Manchester are set to benefit from a new mental hea...

UK Department of Health and Social CareOriginal source
🇺🇰Researchnews.cancerresearchuk.orgTier 2 · Direct publisher

ESMO 2026: Personalised melanoma vaccine, new lung cancer treatments and next-generation targeted drugs

Cancer Research UKOriginal source
🇮🇹Researchpoliclinico.mi.itTier 2 · Direct publisher

#FORMAZIONE. [05.11] Il paziente con demenza in ospedale: verso un Dementia Friendly Hospital

Policlinico di MilanoOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Gilead spends $1.28bn on PepStar’s potential Icotyde rival

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Grand Pharmaceutical Group Limited Estimates – LSX:A0Q8LD

TradingViewOriginal source
🇺🇸Researchnews.nm.orgTier 2 · Direct publisher

Pediatric Patients Celebrate Halloween at Inclusive Trunk-or-Treat

Northwestern MedicineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Morocco’s Bennis family moves to take full control of rival drugmaker Polymedic after building pharmaceutical operations across Europe

Business Insider AfricaOriginal source
🇮🇹Researchpoliclinico.mi.itTier 2 · Direct publisher

#FORMAZIONE. [30.10 e 06.11] Il corpo guaritore ferito: la danza terapia nei contesti di cura e riabilitazione. 22.4 ECM Ultimi giorni per iscriversi!

Policlinico di MilanoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UK Biobank partners with to biotech firms map human immune system

Health Tech WorldOriginal source
🌍discoverynews.google.comTier 2 · Trade media

US Treasury proposes curbs on Chinese biotech deals

pharmaphorumOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Tango Therapeutics Reports 82% Objective Response Rate for Vopimetostat Plus Daraxonrasib in Previously Treated Pancreatic Cancer; Plans Phase 3 Study in 2027

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China Biotech Curbs Could Rattle K-Bio

BusinesskoreaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

At nine months, 88% of 22 pancreatic cancer patients were alive without their cancer worsening.

Stock TitanOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Investors flee riskiest biotech stocks as Treasury yields climb

MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Angel Yeast Marks 40th Anniversary, Setting Its Sights on Becoming a Global Biotech Powerhouse

Chinook ObserverOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Concord Biotech Finds a Winning Formula in Its Active Pharmaceutical Ingredients Business

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bharat Biotech cuts malaria vaccine price by 40% after Unicef-Gavi deal to cover additional 1 million child...

FirstpostOriginal source
🇨🇦Industryir.zymeworks.comTier 1 · Company source

Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3

ZymeworksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Protecting the patent system that powers MD’s biotech future

Maryland Daily RecordOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

newsweek fda weight loss drug

EMYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sun Pharmaceutical Industries Limited

ReutersOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drugs list 2025

EMYOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How One Biotech Stock Is Trying To Reduce A Big Hidden Cost

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda approves new weight-loss drug august 14 2025

BusinessWorld OnlineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

fda proposes restrictions on bulk compounding of popular weight-loss drugs

www.polskieradio.plOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: CONNECTing European living labs for digital health technologies in primary and community CARE (CONNECT-CARE)

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: integrated nano-photonic OMICs bio-SENSor for lung cancer

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Intelligent Ingestible Devices for Gastrointestinal Therapeutics, Diagnosis or Intervention.

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Exploring perineural invasion (PNI) mechanisms in Pancreatic Cancer using hyperpolarized 13C NMR

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Südpack Medica launches recyclable mono-PE sterile barrier for pharma packaging

Packaging InsightsOriginal source